Systemic Inflammation Marks Severity and Treatment Response in Alopecia Areata

January 29, 2026 Dr. Michael Lee – Health Editor Health

Here’s a breakdown of the key findings from the provided text,focusing on the relationship between inflammation and alopecia areata,and ⁢the impact of JAK inhibitor treatment:

Key Findings:

* Severe ‌Alopecia Areata & Inflammation: Patients wiht severe alopecia areata had significantly higher levels of several inflammatory ‍markers in their blood (NLR,PLR,MLR,SII,and ESR) compared to ⁤both those with mild disease and healthy controls.
* Mild Alopecia Areata ‌& Inflammation: patients with mild alopecia areata showed inflammatory marker levels similar to healthy individuals. This⁢ suggests inflammation is more strongly linked to the severe form of the disease.
* JAK Inhibitor Treatment & Inflammation: Treatment with JAK inhibitors (specifically tofacitinib,⁢ often used off-label) in patients with severe alopecia areata was associated with a reduction in inflammatory ⁢markers.
* Specific Marker Changes with Treatment:

‌ * NLR & SII: Decreased ‌significantly ‍with treatment, showing advancement as early as 3 months and further reduction with hair regrowth.
* PLR: Also decreased significantly with treatment.
* ‌ Clinical Improvement & Inflammation: The ​decline in inflammatory markers correlated with clinical ⁢improvement,measured by a reduction in the SALT score (Severity of Alopecia Tool).

in essence, ⁢the study suggests that systemic inflammation is elevated in severe alopecia areata, and that reducing this inflammation with JAK inhibitors can lead to clinical improvement.